Orders from 190 AUD Free delivery from 395 AUD Ready for pickup dead drop: collect in 5 min

Substances · Benzodiazepines and thienodiazepines

Diclazepam

C16H12Cl2N2O CAS 2894-68-0 Analytical reference material — not for human consumption
Preferred name
Diclazepam
IUPAC name
7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one
Parent CAS number (reference)
2894-68-0
Molecular formula
C16H12Cl2N2O
Molecular weight
319.2 g/mol
InChIKey
VPAYQWRBBOGGPY-UHFFFAOYSA-N
PubChem
CID 76168
Source
PubChem
Verified synonyms & catalog abbreviations
2'-Chlorodiazepam Ro 5-3448 Chlorodiazepam

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

Diclazepam

Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM) 1,4-Benzodiazepine
Verified PubChem & CAS Identity C16H12Cl2N2O · CAS 2894-68-0 · CID 76168
Calibrated Physical Form Precision Tablets · 1 Tablet = 1 mg
≥98% Analytical Purity Verified 319.2 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

GABAₐ α₂/α₃ Anxiolysis & Myorelaxation High PAM
GABAₐ α₁ Hypnotic / Sedative Drive Moderate-High
GABAₐ α₅ Amnestic / Cognitive Modulation Moderate

2'-Chlorodiazepam acting at classical benzodiazepine GABA-A sites with ~8–10x the milligram potency of diazepam (~1 mg diclazepam ≈ 10 mg diazepam).

Biotransformation & Active Metabolites

Human metabolism (Moosmann et al.) yields three active pharmaceutical metabolites: delorazepam, lorazepam, and lormetazepam (T1/2 ~42 h).

Temporal Pharmacokinetics

Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM) — 1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation.

  1. Onset 30–75 min
  2. Peak Window 2–4 h
  3. Total Window 8–12 h
  4. Residual / Half-Life 24–48 h active metabolite tail (T1/2 ~42 h)

1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
0.5 mg
Cognitive & Sensory

Subtle threshold receptor activity (Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
0.5–1 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
1–2 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
2–4 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
5+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl)

Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.

Alcohol, GHB/GBL, and Barbiturates

Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.

Elevated Hazard — Avoid

Dissociatives (Ketamine, 2-FDCK, DCK, O-PCE, MXE)

Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.

Caution / Receptor Attenuation

CYP3A4 inhibitors (grapefruit juice, ketoconazole) & Stimulants

CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.

Structural Isomer & Sibling Comparison

1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation.

Physicochemical Stability & Storage

Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.

Store sealed in a cool, dry, light-protected container away from humidity.

Cross-Tolerance & Dependence Profile

Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.

Comprehensive Analytical & Toxicological Monograph

Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one; CAS 2894-68-0, PubChem CID 76168) is a 1,4-benzodiazepine reference compound (C16H12Cl2N2O, 319.2 g/mol) classified pharmacologically as a Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM). 2'-Chlorodiazepam acting at classical benzodiazepine GABA-A sites with ~8–10x the milligram potency of diazepam (~1 mg diclazepam ≈ 10 mg diazepam). Human metabolism (Moosmann et al.) yields three active pharmaceutical metabolites: delorazepam, lorazepam, and lormetazepam (T1/2 ~42 h). In published observational and toxicological literature, threshold response is noted at 0.5 mg, light range at 0.5–1 mg, common reference range at 1–2 mg, strong intensity at 2–4 mg, and heavy/adverse territory at 5+ mg, with an onset of 30–75 min, peak window of 2–4 h, and total duration of 8–12 h (24–48 h active metabolite tail (T1/2 ~42 h)). 1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation. Critical contraindications include Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl), Alcohol, GHB/GBL, and Barbiturates.

Chemical Architecture & Structural Profile

Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one) is a reference compound belonging to the Benzodiazepines and thienodiazepines class, characterized by the molecular formula C16H12Cl2N2O and a molar mass of 319.2 g/mol. The parent molecule is indexed under CAS registry number 2894-68-0 and in the NCBI PubChem database as CID 76168 (Standard InChIKey: VPAYQWRBBOGGPY-UHFFFAOYSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), Diclazepam is indexed within the Benzodiazepines structural group. Toxicological notes (PsychonautWiki): low toxicity, potentially lethal when mixed with depressants like alcohol or opioids. Dependence liability (PsychonautWiki): extremely physically and psychologically addictive. Documented cross-tolerance class: GABAergic. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations